Detailed view for Tb927.8.7530

Basic information

TDR Targets ID: 18643
Trypanosoma brucei, 3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Source Database / ID:  TriTrypDB  GeneDB

pI: 6.6966 | Length (AA): 358 | MW (Da): 39777 | Paralog Number: 1

Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0

Druggability Group : DG2

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00378   Enoyl-CoA hydratase/isomerase

Gene Ontology

Mouse over links to read term descriptions.
GO:0005739   mitochondrion  
GO:0003824   catalytic activity  
GO:0008152   metabolic process  

Metabolic Pathways

Fatty acid metabolism (KEGG)

Structural information

Modbase 3D models:

No model available for this protein in Modbase.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile Procyclic, Bloodstream Form. Siegel TN
Show/Hide expression data references
  • Siegel TN Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites.

Orthologs

Ortholog group members (OG5_130243)

Species Accession Gene Product
Drosophila melanogaster Dmel_CG4594   CG4594 gene product from transcript CG4594-RB
Drosophila melanogaster Dmel_CG4592   CG4592 gene product from transcript CG4592-RB
Drosophila melanogaster Dmel_CG4598   CG4598 gene product from transcript CG4598-RB
Homo sapiens ENSG00000167969   enoyl-CoA delta isomerase 1
Leishmania braziliensis LbrM.31.2600   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania braziliensis LbrM.31.2520   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania braziliensis LbrM.31.2470   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania donovani LdBPK_312400.1   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania donovani LdBPK_312320.1   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania infantum LinJ.31.2400   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania infantum LinJ.31.2320   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania major LmjF.31.2250   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania major LmjF.31.2330   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania mexicana LmxM.30.2330   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Leishmania mexicana LmxM.30.2250   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Mus musculus ENSMUSG00000024132   enoyl-Coenzyme A delta isomerase 1
Mycobacterium ulcerans MUL_4319   enoyl-CoA hydratase, EchA3
Trypanosoma brucei gambiense Tbg972.8.7770   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma brucei gambiense Tbg972.4.5080   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma brucei Tb927.4.4910   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma brucei Tb927.8.7530   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma congolense TcIL3000_8_7780   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma congolense TcIL3000_8_7920   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma cruzi TcCLB.431357.10   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma cruzi TcCLB.509261.30   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Trypanosoma cruzi TcCLB.507107.40   3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative

Essentiality

Tb927.8.7530 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.4.4910 Trypanosoma brucei significant loss of fitness in bloodstream forms (3 days) alsford
Tb927.4.4910 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb927.4.4910 Trypanosoma brucei significant loss of fitness in procyclic forms alsford
Tb927.4.4910 Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
Tb927.8.7530 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.8.7530 this record Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb927.8.7530 this record Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.8.7530 this record Trypanosoma brucei significant loss of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan

Phenotypes and Validation (curated)

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Drugs/Inhibitors
cell proliferation (GO:0008283) normal (PATO:0000461) bloodstream stage trypomastigotes (PLO:0027) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). References: 21363968
cell proliferation (GO:0008283) normal (PATO:0000461) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . References: 21363968
cell proliferation (GO:0008283) decreased (PATO:0000468) procyclic (PLO:0034) inferred from RNAi experiment (ECO:0000019) No drug identifiers listed for this gene.
Annotator: fernan@iib.unsam.edu.ar. Comment: decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . References: 21363968

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Tb927.8.7530 (Trypanosoma brucei), 3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative
Title for this comment
Comment